(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one
3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one
(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]indolin-2-one
3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]indolin-2-one
(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-2-indolinone
3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-2-indolinone
3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]oxindole
(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]oxindole
204005-46-9
194413-58-6
S8442_SIGMA
2H-Indol-2-one, 3-[(3,5-dimethyl-2-pyrrolyl)methylene]-
NSC696819
HSCI1_000303
NCI60_034480
2H-Indol-2-one, 3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)-1,3-dihydro-, (3Z)-
2H-Indol-2-one, 3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)-1,3-dihydro-, (Z)-
3-((Z)-(3,5-Dimethylpyrrol-2-yl)methylene)-2-indolinone
3-(1-(3,5-Dimethyl-1H-pyrrol-2-yl)meth-(Z)-ylidene)-2-oxo-2,3-dihydroindole
Semaxanib
Semaxanib [INN]
Lopac0_001110
SU5416
H-Indol-2-one, 3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)-1,3-dihydro-
SU 5416
Semaxinib
InSolution™ VEGF Receptor 2 Kinase Inhibitor III
NSC-696819
SU-5416
Semoxind
TSU-16
D05819
Semaxanib (USAN)
EU-0101110
3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]indolin-2-one
nchembio778-comp2
3-[(2,4-Dimethylpyrrol-5-yl)methylidene]-indolin-2-one
VEGF Receptor 2 Kinase Inhibitor III
1,3-Dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-2H-indol-2-one